171 related articles for article (PubMed ID: 8148567)
1. Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.
Ringa V; Ledésert B; Bréart G
Osteoporos Int; 1994 Jan; 4(1):16-20. PubMed ID: 8148567
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
3. Why do women doctors in the UK take hormone replacement therapy?
Isaacs AJ; Britton AR; McPherson K
J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
5. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
[TBL] [Abstract][Full Text] [Related]
6. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
9. Determinants of hormonal replacement therapy in recently postmenopausal women.
Ringa V; Ledésert B; Gueguen R; Schiele F; Breart G
Eur J Obstet Gynecol Reprod Biol; 1992 Jul; 45(3):193-200. PubMed ID: 1511767
[TBL] [Abstract][Full Text] [Related]
10. Benefits of hormone replacement therapy in postmenopausal women.
Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.
Amigoni S; Morelli P; Chatenoud L; Parazzini F
Climacteric; 2000 Mar; 3(1):25-32. PubMed ID: 11910606
[TBL] [Abstract][Full Text] [Related]
12. Australian women's perceptions of hormone replacement therapy over 10 years.
Abraham S; Perz J; Clarkson R; Llewellyn-Jones D
Maturitas; 1995 Feb; 21(2):91-5. PubMed ID: 7752955
[TBL] [Abstract][Full Text] [Related]
13. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
Perrone G; Capri O; Borrello M; Galoppi P
Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
[TBL] [Abstract][Full Text] [Related]
14. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
[TBL] [Abstract][Full Text] [Related]
16. Compliance considerations with hormone replacement therapy.
Karakoç B; Erenus M
Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
[TBL] [Abstract][Full Text] [Related]
17. Women's knowledge of and attitudes towards hormone replacement therapy.
Lewin KJ; Sinclair HK; Bond CM
Fam Pract; 2003 Apr; 20(2):112-9. PubMed ID: 12651782
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
[TBL] [Abstract][Full Text] [Related]
19. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy.
Wu F; Ames R; Clearwater J; Evans MC; Gamble G; Reid IR
Clin Endocrinol (Oxf); 2002 Jun; 56(6):703-11. PubMed ID: 12072039
[TBL] [Abstract][Full Text] [Related]
20. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
